Neurology
Cardiology
Atherothrombosis
Atherothrombosis 
Choose from the programs below to view upcoming live events and the associated archived discussions.
NEXT LIVE DISCUSSION:
Tuesday, September 07, 2010 12:15 PM ET
Persistence With Stroke Prevention Medications 3 Months After Hospitalization

Discussants:
Cheryl D. Bushnell, MD, MHS Associate Professor of Neurology Wake Forest University Health Sciences Associate Director Women's Health Center of Excellence for Research, Leadership, Education Wake Forest University Baptist Medical Center Winston-Salem, North Carolina

Moderators:
Christopher P. Cannon, MD Associate Professor of Medicine Harvard Medical School Senior Investigator, TIMI Study Group Cardiovascular Division Brigham and Women’s Hospital Boston, Massachusetts

PREVIOUS DISCUSSIONS:

August 03, 2010

A Risk Score to Predict Bleeding in Patients With Acute Coronary Syndromes


July 06, 2010

The Case for Routine Genotyping in Dual-Antiplatelet Therapy


June 01, 2010

Delays in Filling Clopidogrel Prescription After Hospital Discharge and Adverse Outcomes After Drug-Eluting Stent Implantation: Implications for Transitions of Care


May 04, 2010

Acute Coronary Syndrome: Emerging Tools for Diagnosis and Risk Assessment


April 06, 2010

Cardiovascular Event Rates in Diabetic and Nondiabetic Individuals With and Without Established Atherothrombosis (from the REduction of Atherothrombosis for Continued Health [REACH] Registry)


March 02, 2010

Comparison of Ticagrelor With Clopidogrel in Patients With a Planned Invasive Strategy for Acute Coronary Syndromes (PLATO): A Randomized, Double-Blind Study


February 02, 2010

High Residual Platelet Reactivity After Clopidogrel Loading and Long-Term Clinical Outcomes After Drug-Eluting Stenting for Unprotected Left Main Coronary Disease


November 10, 2009

Ticagrelor versus Clopidogrel in Patients With Acute Coronary Syndromes


October 06, 2009

Pharmacodynamic Effect and Clinical Efficacy of Clopidogrel and Prasugrel With or Without a Proton-Pump Inhibitor: An Analysis of Two Randomised Trials


September 15, 2009

The Use of Intravenous Enoxaparin in Elective Percutaneous Coronary Intervention in Patients With Renal Impairment: Results From the SafeTy and Efficacy of Enoxaparin in PCI patients, an InternationaL Randomized Evaluation (STEEPLE) Trial


August 04, 2009

Standardized Low–Molecular-Weight Heparin Bridging Regimen in Outpatients on Oral Anticoagulants Undergoing Invasive Procedure or Surgery: An Inception Cohort Management Study